0

Journal Articles

in Drug Prescribing Behavior
 1-20 of 84 Articles
Editorial |  June 12, 2013
Putting Antibiotic Prescribing for Children Into Context
Jonathan A. Finkelstein, MD, MPH
JAMA. 2013;309(22):2388-2389. doi:10.1001/jama.2013.6288.
Original Contribution |  June 12, 2013
Effect of an Outpatient Antimicrobial Stewardship Intervention on Broad-Spectrum Antibiotic Prescribing by Primary Care Pediatricians:  A Randomized Trial
Jeffrey S. Gerber, MD, PhD; Priya A. Prasad, MPH; Alexander G. Fiks, MD, MSCE; et al.
JAMA. 2013;309(22):2345-2352. doi:10.1001/jama.2013.6287.
INCLUDES: , Supplemental Content
Viewpoint |  June 05, 2013
Opioid Analgesics—Risky Drugs, Not Risky Patients
Deborah Dowell, MD, MPH; Hillary V. Kunins, MD, MPH, MS; Thomas A. Farley, MD, MPH
JAMA. 2013;309(21):2219-2220. doi:10.1001/jama.2013.5794.
Medical News and Perspectives |  April 17, 2013
“Nightmare” Bacteria on the Rise in US Hospitals, Long-term Care Facilities
Bridget M. Kuehn, MSJ
JAMA. 2013;309(15):1573-1574. doi:10.1001/jama.2013.2922.
Care of the Aging Patient: From Evidence to Action |  April 03, 2013
Management of Human Immunodeficiency Virus Infection in Advanced Age
Meredith Greene, MD; Amy C. Justice, MD, PhD; Harry W. Lampiris, MD; et al.
JAMA. 2013;309(13):1397-1405. doi:10.1001/jama.2013.2963.
INCLUDES: , Supplemental Content
JAMA Patient Page |  April 03, 2013 FREE
Statins
Deborah Tolmach Sugerman, MSW; Edward H. Livingston, MD; Cassio Lynm, MA
JAMA. 2013;309(13):1419. doi:10.1001/jama.2013.3041.
INCLUDES: , Supplemental Content
Viewpoint |  March 06, 2013
Improving Opioid Prescribing:  The New York City Recommendations
David N. Juurlink, MD, PhD; Irfan A. Dhalla, MD, MSc; Lewis S. Nelson, MD
JAMA. 2013;309(9):879-880. doi:10.1001/jama.2013.1139.
Clinical Crossroads |  March 06, 2013
Chronic Back Pain With Possible Prescription Opioid Misuse
Daniel P. Alford, MD, MPH
JAMA. 2013;309(9):919-925. doi:10.1001/jama.2013.522.
INCLUDES: CME
JAMA Clinical Evidence Synopsis |  February 20, 2013
Clinical Outcomes Associated With Procalcitonin Algorithms to Guide Antibiotic Therapy in Respiratory Tract Infections
Philipp Schuetz, MD, MPH; Matthias Briel, MD, MSc; Beat Mueller, MD
JAMA. 2013;309(7):717-718. doi:10.1001/jama.2013.697.
Research Letters |  February 20, 2013
Pharmaceutical Overdose Deaths, United States, 2010
Christopher M. Jones, PharmD; Karin A. Mack, PhD; Leonard J. Paulozzi, MD
JAMA. 2013;309(7):657-659. doi:10.1001/jama.2013.272.
From the Centers for Disease Control and Prevention |  February 13, 2013
Buprenorphine Prescribing Practices and Exposures Reported to a Poison Center—Utah, 2002-2011
JAMA. 2013;309(6):536-538. doi:10.1001/jama.2012.217206.
Viewpoint |  February 06, 2013
FDA Regulation of Off-label Drug Promotion Under Attack
Aaron S. Kesselheim, MD, JD, MPH; Michelle M. Mello, JD, PhD, MPhil; Jerry Avorn, MD
JAMA. 2013;309(5):445-446. doi:10.1001/jama.2012.207972.
Research Letters |  December 05, 2012 FREE
Routine Conflict of Interest Disclosure by Preclinical Lecturers and Medical Students' Attitudes Toward the Pharmaceutical and Device Industries
Azalea Kim, MPA; Lawrence A. Mumm, BA; Deborah Korenstein, MD
JAMA. 2012;308(21):2187-2189. doi:10.1001/jama.2012.25315.
Viewpoint |  November 14, 2012
Rethinking Opioid Prescribing to Protect Patient Safety and Public Health
G. Caleb Alexander, MD, MS; Stefan P. Kruszewski, MD; Daniel W. Webster, ScD, MPH
JAMA. 2012;308(18):1865-1866. doi:10.1001/jama.2012.14282.
Viewpoint |  October 10, 2012
The FDA Safety and Innovation Act
Robert Steinbrook, MD; Joshua M. Sharfstein, MD
JAMA. 2012;308(14):1437-1438. doi:10.1001/jama.2012.12829.
Medical News and Perspectives |  October 03, 2012
IDSA: Avoid Antibiotics for Most Throat Infections
Bridget M. Kuehn
JAMA. 2012;308(13):1307. doi:10.1001/jama.2012.13019.
Research Letters |  September 12, 2012 FREE
Changes in Direct-to-Consumer Pharmaceutical Advertising Following Shifts From Prescription-Only to Over-the-Counter Status
Jeremy A. Greene, MD, PhD; Niteesh K. Choudhry, MD, PhD; Aaron S. Kesselheim, MD, JD, MPH; et al.
JAMA. 2012;308(10):973-975. doi:10.1001/2012.jama.10647.
Medical News and Perspectives |  September 05, 2012
European Drug Agency Works to Improve Transparency, but Skepticism Remains
Tracy Hampton, PhD
JAMA. 2012;308(9):850-851. doi:10.1001/2012.jama.10451.
Viewpoint |  August 01, 2012
Curbing the Opioid Epidemic in the United States:  The Risk Evaluation and Mitigation Strategy (REMS)
Lewis S. Nelson, MD; Jeanmarie Perrone, MD
JAMA. 2012;308(5):457-458. doi:10.1001/jama.2012.8165.
Medical News and Perspectives |  March 07, 2012
Effects of FDA Safety Warnings May Vary
Bridget M. Kuehn
JAMA. 2012;307(9):894-895. doi:10.1001/jama.2012.217.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
RESEARCH LETTER  |  June 10, 2013
Cumulative Changes in the Use of Long-Term Medications: A Measure of Prescribing Complexity
Khoa D. Lam, MD; Yinghui Miao, MPH; Michael A. Steinman, MD
JAMA Internal Medicine
Research Letters  |  June 3, 2013
Trends in Androgen Prescribing in the United States, 2001 to 2011
Jacques Baillargeon, PhD; Randall J. Urban, MD; Kenneth J. Ottenbacher, PhD, OTR; et al.
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Internal Medicine
Research Letters  |  April 22, 2013
Trends in On-label and Off-label Modafinil Use in a Nationally Representative Sample
Renée A. Peñaloza, MS; Urmimala Sarkar, MD, MPH; David M. Claman, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems